Cyclin-dependent kinase 4/6 inhibition in the treatment of hormone receptor-positive breast cancer.

Cyclin-dependent kinase 4/6 inhibition in the treatment of hormone receptor-positive breast cancer. Clin Adv Hematol Oncol. 2019 Oct;17(10):555-558 Authors: Rugo HS PMID: 31730581 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research